Funded Tech Companies

Attralus

Researching who provided funding to Attralus? Vivo Capital, venBio and Logos Capital joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Its proprietary peptide-based pan-amyloid targeting agents have the potential to diagnose and treat all forms and stages of systemic amyloidosis.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/9/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Timney

        

Chief Financial Officer

Benson Fong

        

Chief Medical Officer

Gregory Bell

        

Chief Operating Officer

Spencer Guthrie

        

Chief Scientific Officer

Jonathan Wall

        

VP - Bus. Development

Glen Firestone

        

VP - Bus. Development

Krishna Gorti

        

VP - Human Resources

Christine Huh

        

Company Investors

• Vivo Capital
• venBio (Richard Gaster)
• Logos Capital (Graham Walmsley)
• Samsara BioCapital
• Redmile Group
• Sarissa Capital
• Janus Henderson Investors
• Surveyor Capital

Browse more funded tech companies:

Attovia Therapeutics | Attributor

Share this article

About Our VC & M&A Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary